Pro-proliferative FoxM1 is a target of p53-mediated repression

被引:126
|
作者
Barsotti, A. M. [1 ]
Prives, C. [1 ]
机构
[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
基金
美国国家卫生研究院;
关键词
p53; FoxM1; transcriptional repression; p21; Rb; G2; arrest; M1 TRANSCRIPTION FACTOR; P53; TUMOR-SUPPRESSOR; MOUSE-LIVER REGENERATION; CELL-CYCLE PROGRESSION; WILD-TYPE P53; DNA-DAMAGE; DOWN-REGULATION; C-MYC; FUNCTIONAL DOMAINS; INDUCED SENESCENCE;
D O I
10.1038/onc.2009.282
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor protein acts as a transcription factor to modulate cellular responses to a wide variety of stresses. In this study we show that p53 is required for the downregulation of FoxM1, an essential transcription factor that regulates many G2/M-specific genes and is overexpressed in a multitude of solid tumors. After DNA damage, p53 facilitates the repression of FoxM1 mRNA, which is accompanied by a decrease in FoxM1 protein levels. In cells with reduced p53 expression, FoxM1 is upregulated after DNA damage. Nutlin, a small-molecule activator of p53, suppresses FoxM1 levels in two cell lines in which DNA damage facilitates only mild repression. Mechanistically, p53-mediated inhibition of FoxM1 is partially p21 and retinoblastoma (Rb) family dependent, although in some cases p21-independent repression of FoxM1 was also observed. The importance of FoxM1 to cell fate was indicated by the observation that G2/M arrest follows FoxM1 ablation. Finally, our results indicate a potential contribution of p53-mediated repression of FoxM1 for maintenance of a stable G2 arrest. Oncogene (2009) 28, 4295-4305; doi: 10.1038/onc.2009.282; published online 14 September 2009
引用
收藏
页码:4295 / 4305
页数:11
相关论文
共 50 条
  • [41] Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression
    Spurgers, Kevin B.
    Gold, David L.
    Coombes, Kevin R.
    Bohnenstiehl, Nicole L.
    Mullins, Brian
    Meyn, Raymond E.
    Logothetis, Christopher J.
    McDonnell, Timothy J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (35) : 25134 - 25142
  • [42] FOXM1 Immunoreactivity Correlates with Proliferative Index and Clinical Outcome in Meningioma
    Lucas, Calixto-Hope
    Magill, Stephen
    Choudhury, Abrar
    Vasudevan, Harish
    Ferris, Sean
    Pekmezci, Melike
    Gopinath, Chetna
    Phillips, Joanna
    Perry, Arie
    Solomon, David
    Raleigh, David
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1615 - 1616
  • [43] FOXM1 Immunoreactivity Correlates with Proliferative Index and Clinical Outcome in Meningioma
    Lucas, Calixto-Hope
    Magill, Stephen
    Choudhury, Abrar
    Vasudevan, Harish
    Ferris, Sean
    Pekmezci, Melike
    Gopinath, Chetna
    Phillips, Joanna
    Perry, Arie
    Solomon, David
    Raleigh, David
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1615 - 1616
  • [44] HUMAN PAPILLOMAVIRUS E6 PROTEINS BIND P53 INVIVO AND ABROGATE P53-MEDIATED REPRESSION OF TRANSCRIPTION
    LECHNER, MS
    MACK, DH
    FINICLE, AB
    CROOK, T
    VOUSDEN, KH
    LAIMINS, LA
    EMBO JOURNAL, 1992, 11 (08): : 3045 - 3052
  • [45] The anti-apoptotic and pro-proliferative p53-related DN-p73 protein is expressed in human HCC
    Palescandolo, E
    Costanzo, A
    Vossio, S
    Pediconi, N
    Merlo, P
    Almerighi, C
    Fulco, M
    Cariani, E
    Balsano, C
    Levrero, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 81 - 82
  • [46] FoxM1 is a Novel Target of a Natural Agent in Pancreatic Cancer
    Wang, Zhiwei
    Ahmad, Aamir
    Banerjee, Sanjeev
    Azmi, Asfar
    Kong, Dejuan
    Li, Yiwei
    Sarkar, Fazlul H.
    PHARMACEUTICAL RESEARCH, 2010, 27 (06) : 1159 - 1168
  • [47] FoxM1 is a promising candidate target in the treatment of breast cancer
    Lu, Xiao-Feng
    Zeng, De
    Liang, Wei-Quan
    Chen, Chun-Fa
    Sun, Shu-Ming
    Lin, Hao-Yu
    ONCOTARGET, 2018, 9 (01) : 842 - 852
  • [48] FOXM1: a new therapeutic target of extramammary Paget disease
    Takamichi Ito
    Yuka Tanaka
    Yumiko Kaku-Ito
    Yoshinao Oda
    Takeshi Nakahara
    Scientific Reports, 14
  • [49] LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53
    Zhou, Xinliang
    Sang, Meixiang
    Liu, Wei
    Gao, Wei
    Xing, Enhong
    Lu, Weihua
    Xu, Yingying
    Fan, Xiaojie
    Jing, Shaowu
    Shan, Baoen
    LIFE SCIENCES, 2012, 91 (9-10) : 358 - 363
  • [50] Hepatitis B viral transactivator HBx alleviates p53-mediated repression of α-fetoprotein gene expression
    Ogden, SK
    Lee, KC
    Barton, MC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (36) : 27806 - 27814